Bioventus (BVS) Total Debt (2020 - 2026)

Bioventus (BVS) has 7 years of Total Debt data on file, last reported at $272.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt fell 14.75% year-over-year to $272.1 million; the trailing twelve-month figure through Mar 2026 stood at $272.1 million (down 14.75% YoY), and the FY2025 full-year result was $294.0 million, down 10.34% from the prior year.
• Total Debt for Q1 2026 stood at $272.1 million, down from $294.0 million in the prior quarter.
• Across five years, Total Debt topped out at $445.6 million in Q2 2023 and bottomed at $272.1 million in Q1 2026.
• The 5-year median for Total Debt is $367.0 million (2023), against an average of $363.2 million.
• The widest annual swing landed in 2022, when Total Debt surged 139.19%; it then slipped 18.42% in 2025.
• A 5-year view of Total Debt shows it stood at $418.1 million in 2022, then declined by 12.22% to $367.0 million in 2023, then retreated by 10.66% to $327.9 million in 2024, then slipped by 10.34% to $294.0 million in 2025, then dropped by 7.44% to $272.1 million in 2026.
• The last three Total Debt figures came in at $272.1 million (Q1 2026), $294.0 million (Q4 2025), and $322.6 million (Q3 2025), per Business Quant data.

Peer Comparison